Борьба с вирусом папилломы человека

1. Дубенский В.В. Урогенитальная папилломавирусная инфекция
(обзор литературы). Рос. журн. кожн. и венерич. бол. 2000; 5:
50–5.
2. Л.Б.Борисов, А.М.Смирнова, И.С.Фрейдлин и др. Медицинская мик-
робиология, вирусология, иммунология: Учебник. Под ред. Л.Б.Бори-
сова, А.М.Смирновой. М.: Медицина, 1994.
3. Козлова В.И., Пухнер А.Ф. Вирусные, хламидийные и микоплаз-
менные заболевания гениталий. Руководство для врача. М.: ИИД
«Филин», 1997.
4. Nindl I, Lotz B, Kuhne Heid R et al. Distribution of 14 high risk HPV
types in cervical intraepithelial neoplasia detected by a non-radioactive
general primer PCR mediated enzyme immunoassay. J Clin Pathol
1999; 52 (1): 17–22.
5. Boxman IL, Hogowoning A, Mulder LH et al. Detection of human
papillomavirus types 6 and 11 in pubis and perianal hair from
patients with genital warts. J Clin Microbiol 1999; 37 (7): 2270–3.
6. Merkelbach Bruse S, Jacob C, Tietze L et al. Consensus polymerase
chain reaction and enzymelinked immuno-sorbent assay from human
papillomavirus detection and typing in cervical speciment. Diagn Mol
Pathol 1999; 8 (1): 32–8.
7. Milde Langosch K, Riethdorf S, Park TW. Naturlicher Verlauf der HPVinfection.
Nutzen der of HPV-infection Usefulness of HPV analysis in
cervix diagnosis. Pathology 1999; 20 (1): 15–24.
8. Zechbe I, Voglino G, Wilander E et al. Codon 72 polymorphism of p53
and its association with cervical cancer [letter]. Lancet 1999; 17, 354
(9174): 218–9.
9. Li X, Mi R, Jiao S et al. Overexpression of p53 protein and its relation
to HPV in squamous intraepithelial lesion and cervical carcinoma. J
Clin Pathol 1999; 52 (1): 17–22.
10. Yamashita T, Yaginuma Y, Saitoh Y et al. Codon 72 polymorphism of
p53 as a risk factor for patients with human papillomavirus-associated
squamous intraepithelial lesions and invazive cancer of the uterine
cervix. Carcinogenesis 1999; 20 (9): 1733–6.
11. Tachezy R, Hamzicova E, Hajek T et al. Human papillomavirus
genotype spectrum in Czech Women: correlation of HPPV DNA presence
with antibodies against HPV-16, 18 and 33virus-like particles. J Med
Virol 1999; 58 (4): 378–86.
12. Chan PK, Li WH, Chan MY et al. High prevalence of human papillomavirus
type 58 in Chinese women with cervical cancer and precancerous
lesions. J Med Virol 1999; 59 (2): 232–8.
13. Лолор Г.-младший, Фишер Т., Адельман Д. Клиническая иммуно-
логия и аллергология. Пер. с англ. М.: «Практика», 2000.
14. Stanley M. The immunology of genital human papillomavirus infection.
Eue J Dermatol; 1998; 8 (Suppl. 7): 8012.
15. Sedlacek TV. Advances in the diagnosis and treatment of human
papillomavirus infection. Clin Obstet Gynnecol 1999; 42 (2): 206–20.
16. Yoshicava H, Nagata C, Noda C et al. Human papillomavirus infection
and other risk factors for cervical intraepithelial neoplasia in
Japan. Br J Cancer 1999; 80 (3–4): 621–4.
17. Atlante M, Pagnini M, Villaccio B et al. L’infezione da HPV come
malattia di coppia. Prevalenza dell’infezionenel partner maschile. Minerva
Ginecol 1999; 51 (5): 161–4.
18. Frega A, Stentella P, Villani C et al. Correlation between cervical
intraepithelial neoplasia and human papillomavirus male infections: a
longitudinal study. Eur J Gynaecol Oncol 1999; 20 (3): 228–30.
19. Kinghorn GR, McMillan A, Mulcahy F et al. Int J STD AIDS 1993; 4
(4): 194–9.
20. Wang B, Shao Y, Chung Kuo I Hsueh Ko Hsueh Yuan Hsueh Pao
1994; 16 (2): 122–5.